W Now, WSW Go - Annals of Internal Medicine - Am Coll Physicians Cardiovascular disease mortality continues to decline, but patients with left ventricular
dysfunction, espe- cially if it results from coronary artery disease, remain at high risk for both
sudden and nonsudden death (1–4). In 1998, the latest year for which US statistics are ... Related articles
AE Buxton, KE Ellison, MM Kirk, B Frain, C Koo, G … - Journal of Interventional …, 2003 - Springer Abstract. Over the past decade, four randomized, con- trolled trials have evaluated therapies
for prevention of sudden cardiac death in patients with coronary disease. Three of the four trials
have shown significant reduc- tions in mortality with implanted defibrillators. Two studies ... Cited by 6 - Related articles - BL Direct - All 4 versions
- ►shouxi.net AE Buxton - The New England journal of medicine, 2005 - nejm.highwire.org The type of arrhythmia observed depends on the temporal relation to myocardial infarction. In
the acute phase of myocardial infarction, the metabolic consequences of severe ischemia may
trigger ventricular fibrillation, even though ventricular function was often normal before the ... Cited by 18 - Related articles - All 7 versions
AJ Moss - tape.com.tr Clinical Implications of the MADIT-II Trial 57 F^atients with coronary heart disease die "either
from progressive heart failure or from a cardiac arrhythmia, mostly ventricular fibrillation. The
available data sug- gest that sudden arrhythmic death accounts for 50% or more of all ... Related articles
AJ Moss - ACC Current Journal Review, 2003 - Elsevier The implantable cardioverter-defibrillator (ICD) was introduced in 1980 to prevent sudden death
in high-risk patients with cardiac disease who had failed medical therapy. Several randomized
clinical trials comparing ICD therapy against conventional and/or specific antiarrhythmic ... Related articles - All 3 versions
SM Greenberg, AE Epstein, T Deering, DS … - Pacing Clin …, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 12 - Related articles - BL Direct - All 4 versions
AE Buxton - Implantable cardiac pacemakers and defibrillators: all …, 2006 - books.google.com CHAPTERS Indications for the implanted cardio verter-defibrillator Alfred E. Buxton The implantable
defibrillator was introduced to clinical medicine in 1980.1 This device, invented by Michel
Mirowski, has revolutionized the care of patients with ventricular arrhythmias. Spurred by ... Related articles - All 2 versions
AJ Moss - Annals of noninvasive electrocardiology: the official …, 2002 - ncbi.nlm.nih.gov 1: Ann Noninvasive Electrocardiol. 2002 Jul;7(3):179-80. MADIT-II and implications
for noninvasive electrophysiologic testing. Moss AJ. Publication Types: Editorial. Mesh
Terms: Arrhythmias, Cardiac/diagnosis; Arrhythmias, Cardiac ... Cited by 6 - Related articles - BL Direct - All 2 versions
- ►oxfordjournals.org AJ Moss - European heart journal, 2003 - Eur Soc Cardiology Prior to the start-up of MADIT-II, three randomized, placebo-controlled, clinical trials showed
that amiodarone was not effective in reducingall-cause mortality in patients with coronary disease
and varying degrees of left ventricular dysfunction. 5–7 MADIT-II was initiated in July ... Cited by 34 - Related articles - BL Direct - All 3 versions
AJ MOSS - Journal of cardiovascular electrophysiology, 2003 - clinicasaadi.com.br MADIT-I and MADIT-II.The MADIT-I study was a proof-of-principle study, and this randomized
trial showed that the implantable cardioverter defibrillator (ICD) saves lives in high-risk patients
with coronary heart disease. The MADIT-II study showed that prophylactic ICD therapy ... Cited by 24 - Related articles - BL Direct - All 6 versions
